The length of puncturable subclavian vein and the available angle for needle insertion were significantly greater with caudal traction compared with a neutral position of the arm.
There is some evidence that a supraclavicular approach to subclavian vein cannulation with ultrasound guidance may be safer than the traditional landmark-based subclavian approach. Using an ultrasound probe placed above the clavicle, investigators in Korea measured the puncturable length of the subclavian vein and the available angle for needle insertion in 20 infants, 20 young children, and 20 adults undergoing general anesthesia. Measurements were taken with the ipsilateral arm in neutral, caudal traction, and abduction positions.
The length of puncturable subclavian vein and the available angle for needle insertion increased significantly with caudal traction compared with the neutral position (increases of 35.6% and 25.0%, respectively),…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals